Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU)

NYSEARCA: TBXU · Real-Time Price · USD
36.01
+1.47 (4.25%)
Feb 27, 2026, 4:00 PM EST - Market closed
4.25%
Assets $3.64M
Expense Ratio 0.97%
PE Ratio n/a
Shares Out 100,001
Dividend (ttm) $0.41
Dividend Yield 1.15%
Ex-Dividend Date Dec 23, 2025
Payout Ratio n/a
1-Year Return n/a
Volume 212
Open 35.25
Previous Close 34.54
Day's Range 35.25 - 36.01
52-Week Low 25.71
52-Week High 38.89
Beta n/a
Holdings 12
Inception Date Oct 1, 2025

About TBXU

Fund Home Page

The Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is an exchange-traded fund that mostly invests in health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry. TBXU was launched on Oct 1, 2025 and is issued by Direxion.

Asset Class Equity
Category Trading--Leveraged Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol TBXU
ETF Provider Direxion
Index Tracked NYSE Biotechnology Top 5 Equal Weight Index

Top 10 Holdings

107.36% of assets
Name Symbol Weight
Dreyfus Govt Cash Man Ins n/a 25.16%
Goldman Finl Sq Trsry Inst 506 n/a 21.53%
Gilead Sciences, Inc. GILD 10.82%
Amgen Inc. AMGN 10.81%
Vertex Pharmaceuticals Incorporated VRTX 9.62%
Regeneron Pharmaceuticals, Inc. REGN 9.44%
argenx SE ARGX 7.95%
Dx D Biotech T 5 Bull 2x Etf Swap n/a 5.43%
Goldman Sachs Fin Gov 465 Institut n/a 4.57%
Dx D Biotech T 5 Bull 2x Etf Swap n/a 2.03%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 23, 2025 $0.10111 Dec 31, 2025
Dec 10, 2025 $0.31143 Dec 17, 2025
Full Dividend History

News

Trade the Titans: Direxion Debuts New Suite of Leveraged & Inverse ETFs

New York, United States, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Direxion, a leading provider of tactical ETFs, today announced the launch of the Direxion Titans Leveraged & Inverse ETFs, a new suite of fun...

Other symbols: TEXUTSXDTSXUTTXDTTXU
5 months ago - GlobeNewsWire